FDA Approves First Drug for Cholestatic Pruritus in Primary Biliary Cholangitis
The U.S. Food and Drug Administration has approved linerixibat, marking the first treatment specifically indicated for cholestatic pruritus in patients with Primary Biliary Cholangitis. The announcement was made by GlaxoSmithKline,…